期刊文献+

DLC-1基因甲基化检测与肝细胞癌复发转移的关系 被引量:2

Relationship between methylation status of DLC-1 gene and metastasis of hepatocellular carcinoma
下载PDF
导出
摘要 目的:研究DLC-1基因甲基化检测与肝细胞癌(hepatocellular carcinoma,HCC)复发转移的关系.方法:73例HCC标本依据临床以及病理学特征被分为高侵袭组和低侵袭组;采用甲基化特异性PCR对不同侵袭组HCC之间DLC-1基因甲基化表达进行分析.结果:DLC-1甲基化表达率高侵袭组明显高于低侵袭组,二者之间有明显差异(χ2=4.3567P<0.05).DLC-1甲基化阳性与阴性患者之间AFP、HBV双阳性率有明显差异(χ2=4.4224P<0.05);TNM分期越后DLC-1甲基化程度越高(χ2=10.8478,P<0.05);短期随访发现DLC-1甲基化的HCC患者中位生存期低于非甲基化患者(9.45movs36mo,P<0.05).结论:DLC-1基因甲基化可作为HCC复发转移监测指标,并可作为靶向治疗HCC复发转移的新靶点. AIM: To investigate the relationship between the methylation status of DLC-1 gene and metastasis of hepatocellular carcinoma (HCC). METHODS: Seventy-three surgical specimens of human HCC were divided into high- and low-invasion groups according to their clinicopathological features. The methylation status of DLC-1 gene was detected in both groups by methylation-specific polymerase chain reaction (MSP). RESULTS: The methylation level of DLC-1 gene in HCC specimens with high invasion was significantly higher than that in specimens with low invasion (χ^2 = 4.3567, P 〈 0. 05). The doublepositive rate of alpha-fetoprotein (AFP) andhepatitis B virus (HBV) was significantly different between methylation-positive and -negative specimens (χ^2 = 4.4224, P 〈 0.05). The methyla- tion status of DLC-1 gene was also related to TNM stages (χ^2 = 10.8478, P 〈 0.05). After shortterm following-up, the median survival time was significantly different between HCC patients with positive- and negative methylation of DLC-1 gene (9.45 mo vs 36 mo, P 〈 0.05). CONCLUSION: The aberrant methylation of DLC-1 gene may not only offer an effective method for the early auxiliary diagnosis of invasion and metastasis, but also serve as an new target for HCC therapies.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第11期1237-1240,共4页 World Chinese Journal of Digestology
基金 江苏省南通市科技局课题资助项目 No.ntzl200305~~
关键词 肝细胞癌 转移 甲基化 DLC-1 甲基化特异性PCR Hepatocellular carcinoma Metastasis Methylation DLC-1 Methylation-specific polymerase chain reaction
  • 相关文献

参考文献15

  • 1Yuan BZ,Zhou X,Durkin ME,Zimonjic DB,Gumundsdottir K,Eyfjord JE,Thorgeirsson SS,Popescu NC.DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.Oncogene 2003; 22:445-450
  • 2Yuan BZ,Miller MJ,Keck CL,Zimonjic DB,Thorgeirsson SS,Popescu NC.Cloning,characterization,and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1)homologous to rat RhoGAP.Cancer Res 1998; 58:2196-2199
  • 3Herman JG.Hypermethylation of tumor suppressor genes in cancer.Semin Cancer Biol 1999;9:359-367
  • 4Jones PL,Wolffe AP.Relationships between chromatin organization and DNA methylation in determining gene expression.Semin Cancer Biol 1999;9:339-347
  • 5Yuan BZ,Durkin ME,Popescu NC.Promoter hypermethylation of DLC-1,a candidate tumor suppressor gene,in several common human cancers.Cancer Genet Cytogenet 2003;140:113-117
  • 6Ng IO,Liang ZD,Cao L,Lee TK,DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.Cancer Res 2000;60:6581-6584
  • 7Wong CM,Lee JM,Ching YP,Jin DY,Ng IO.Genetic and epigenetic alterations of DLC-1 Gene in hepatocellular cancinoma.Cancer Res 2003;63:7646-7651
  • 8Goodison S,Yuan J,Sloan D,Kim R,Li C,Popescu NC,Urquidi V.The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.Cancer Res 2005;65:6042-653
  • 9宋丽杰,叶胜龙,王凯峰,翁永强,梁春敏,孙瑞霞,赵燕,刘银坤,汤钊猷.DLC-1基因表达与肝细胞癌复发转移的关系[J].中华肝脏病杂志,2005,13(6):428-431. 被引量:21
  • 10陈龙邦,林勍,唐永明,王晶.原发性肝癌患者血清p16和DAPK基因启动子甲基化的研究[J].肿瘤防治研究,2006,33(3):175-177. 被引量:3

二级参考文献9

共引文献22

同被引文献30

  • 1刘文姬,王莉,汪建平,李锦清,张昌卿,郑列,元云飞.CpG岛甲基化表型及OPCML基因甲基化与肝细胞癌发生的关系[J].癌症,2006,25(6):696-700. 被引量:11
  • 2王永忠,罗立波,吴国祥,陈敏,阮丽花,濮翔科,杭双荣.微量离心柱法分离检测甲胎蛋白异质体(AFP-L3)及其临床意义[J].中华实验和临床病毒学杂志,2007,21(2):135-137. 被引量:19
  • 3Sterling RK, Jeffers L, Gordon F, et al. Utility of lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gammacarboxy prothmmbin, alone or in combination, as biomarkers for hepatocelhllar carcinoma[J]. Clin Gastroenterol Hepatol, 2009, 7 (1) :104-13.
  • 4Kinoshita Y, Tajiri T, Souzaki R, et al. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors : prchminary study [ J ]. J Pediatr Hematol Oncol, 2008, 30(6) :447-450.
  • 5Cheng HT, Chang YH, Chen YY, et al. AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein [ J ]. J Chin Med Assoc, 2007, 70(8):310-317.
  • 6Hagiwara S, Kudo M, Kawasaki T, et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma[J]. J Gastroenterol, 2006, 41(12):1214-1219.
  • 7Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection [ J ]. Gene, 2000, 249 ( 1-2 ) :53-65.
  • 8Iftikhar R, Kladney RD, Havlioglu N, et al. Disease- and cell- specific expression of GP73 in human liver disease[J]. Am J Gastroenterol, 2004, 99 (6) : 1087-1095.
  • 9Gu Y, Chen W, Zhao Y, et al. Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases [J]. Ann Clin Biochem, 2009, 46(Pt 1) :38-43.
  • 10Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma[J]. J Hepatol, 2005, 43(6):1007-1012.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部